Ratings by Wedbush (Laura Chicho)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
3/16/2026 Maze Therapeutics MAZE Maintain Outperform
(N/A)
 
 
  Details
2/24/2026 Gossamer Bio Inc. GOSS Downgrade Neutral
(Outperform)
0.42
(0.19)
-54.76% Details
7/8/2025 Maze Therapeutics MAZE New Coverage Outperform
(N/A)
12.12
(24.86)
105.12% Details
4/5/2024 Gossamer Bio Inc. GOSS New Coverage Outperform
(N/A)
1.11
(0.42)
-62.16% Details